Results: After clinical pharmacists interventions, there has been a statistically significant increase in the rate of the appropriate risk evaluation and choice of VTE prophylaxis method (from 59.4% to 97.0%, p < 0.05), the number of patients indicated VTE prophylaxis (from 71.4% to 91.8%, p = 0.001) and the overall appropriateness in VTE prophylaxis (from 42.5% to 88.0%, p < 0.05).